tradingkey.logo

Bone Biologics Corp

BBLG

2.755USD

+0.025+0.92%
Horarios del mercado ETCotizaciones retrasadas 15 min
9.01MCap. mercado
PérdidaP/E TTM

Bone Biologics Corp

2.755

+0.025+0.92%
Más Datos de Bone Biologics Corp Compañía
Bone Biologics Corporation is a developer of orthobiologic products for spine fusion markets. It is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications. It is a medical device company that is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with demineralized bone matrix (DBM), is an osteopromotive recombinant protein that provides target specific control over bone regeneration. Its platform technology is its NELL-1, a proprietary skeletal specific growth factor which is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
Información de la empresa
Símbolo de cotizaciónBBLG
Nombre de la empresaBone Biologics Corp
Fecha de salida a bolsaNov 27, 2015
Director ejecutivoMr. Jeffrey Frelick
Número de empleados2
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 27
Dirección2 Burlington Woods Dr Ste 100
CiudadBURLINGTON
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal01803-4551
Teléfono17815524452
Sitio Webhttps://www.bonebiologics.com/
Símbolo de cotizaciónBBLG
Fecha de salida a bolsaNov 27, 2015
Director ejecutivoMr. Jeffrey Frelick
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+0.84%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Jody Cain
Mr. Jody Cain
Investor Relation
Investor Relation
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+0.84%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Jody Cain
Mr. Jody Cain
Investor Relation
Investor Relation
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mar., 8 de jul
Actualizado: mar., 8 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Intracoastal Capital, L.L.C.
9.25%
Geode Capital Management, L.L.C.
0.25%
Sabby Management, LLC
0.10%
Frelick (Jeffrey)
0.02%
Walsh (Deina H)
0.02%
Other
90.35%
Accionistas
Accionistas
Proporción
Intracoastal Capital, L.L.C.
9.25%
Geode Capital Management, L.L.C.
0.25%
Sabby Management, LLC
0.10%
Frelick (Jeffrey)
0.02%
Walsh (Deina H)
0.02%
Other
90.35%
Tipos de accionistas
Accionistas
Proporción
Corporation
9.25%
Investment Advisor/Hedge Fund
0.35%
Individual Investor
0.04%
Hedge Fund
0.02%
Other
90.33%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
26
155.16K
9.67%
+120.59K
2025Q1
27
6.66K
1.22%
-34.55K
2024Q4
36
139.64K
4.27%
-177.16K
2024Q3
35
174.78K
6.98%
-106.17K
2024Q2
34
138.99K
16.02%
-43.94K
2024Q1
34
123.42K
15.56%
-19.42K
2023Q4
32
43.06K
6.51%
-99.40K
2023Q3
31
101.95K
29.59%
-11.73K
2023Q2
29
107.23K
61.29%
+36.20K
2023Q1
27
41.68K
59.89%
-1.33K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Intracoastal Capital, L.L.C.
148.50K
9.25%
+148.50K
--
Jun 27, 2025
Geode Capital Management, L.L.C.
4.03K
0.25%
+1.48K
+57.64%
Mar 31, 2025
Sabby Management, LLC
1.65K
0.1%
+1.65K
--
Dec 31, 2023
Frelick (Jeffrey)
359.00
0.02%
+3.00
+0.84%
Apr 11, 2025
Walsh (Deina H)
313.00
0.02%
--
--
Apr 11, 2025
Tower Research Capital LLC
304.00
0.02%
-261.00
-46.19%
Mar 31, 2025
BofA Global Research (US)
4.00
0%
+1.00
+33.33%
Mar 31, 2025
Meikle (Phillip Terry II)
2.00
0%
--
--
Apr 11, 2025
HRT Financial LP
--
0%
-2.44K
-100.00%
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Dec 18, 2023
Merger
8<1
Dec 18, 2023
Merger
8<1
Dec 18, 2023
Merger
8<1
Dec 18, 2023
Merger
8<1
Jun 06, 2023
Merger
30<1
Jun 06, 2023
Merger
30<1
Fecha
Tipo
Relación
Dec 18, 2023
Merger
8<1
Dec 18, 2023
Merger
8<1
Dec 18, 2023
Merger
8<1
Dec 18, 2023
Merger
8<1
Jun 06, 2023
Merger
30<1
Jun 06, 2023
Merger
30<1
Jun 06, 2023
Merger
30<1
Jun 06, 2023
Merger
30<1
KeyAI